UK data support Shield's heart test as US trial falls apart
This article was originally published in Clinica
Executive Summary
A blood-clotting test manufactured by Scottish company Shield Diagnostics could be a better predictor of heart disease than measurements of lipid levels or fibrinogen. However, a large US trial that could have linked the test to long-term outcomes has gone badly wrong.